Thioctic Acid for Hair Regrowth - Quick Reference Sheet
evipedia.aidev
← Back

Thioctic Acid for Hair Regrowth

Created on 08/24/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4.5 – Audit

Thioctic acid is sold as a supplement and in some countries as a nerve-pain medicine. Short-term nerve-pain relief is the strongest signal; longer-term analyses found little effect, with smaller weight and blood-sugar effects. No randomized trial tested it for pattern thinning. Safety in placebo-controlled trials at 600 mg daily is generally favorable, nausea at higher amounts. Hair regrowth remains speculative. (Full Review)

Protocol

Oral neuropathy-style dose (Ziegler / German clinics)
600 mg racemic (mixed R/S) once daily
Nerve-pain dose, not a hair-count dose; no hair-specific protocol
Time of day
Morning, 30–60 minutes before food
Night dosing is not required; plasma half-life about 30 minutes
Competing hair methods
Not a substitute
Topical minoxidil and oral finasteride or dutasteride remain the interventions with hair-count trials
Time to effect
Symptom Relief in Diabetic Nerve Damage
1–3 weeks
Short-term neuropathy programs
Smoother Appearance of Sun-Damaged Facial Skin
12 weeks
5% cream twice daily; facial texture, not scalp hair
Failure to Prevent Chemotherapy Hair Loss
Did not prevent acute shed
Expected during chemotherapy; 1% derivative lotion

Benefits

Contraindications
  • Prior insulin autoimmune syndrome (Hirata disease) or unexplained hyperinsulinemic hypoglycemia after a sulfur-drug exposure
  • Known HLA-DRB1*04:06 (or related high-risk class II genotype) when the indication is cosmetic hair
  • Children (unintentional ingestion has caused status epilepticus)
  • Pregnancy and lactation, outside a clinician-supervised metabolic protocol
  • Unrepleted thiamine deficiency (including active alcoholism)
  • Prior NELL1 membranous nephropathy or unexplained heavy proteinuria after a thiol-drug exposure
  • Documented severe hypersensitivity to thioctic acid or formulation excipients
    •
Key Interactions
  • Glucose-lowering drugs (insulin, sulfonylureas such as glyburide and glipizide, meglitinides such as nateglinide)
  • Anticoagulants and antiplatelets (warfarin, clopidogrel, aspirin)
  • Common over-the-counter drugs (analgesics, antacids, antihistamines; aspirin)
  • Levothyroxine and other thyroid replacement
  • Mineral supplements (iron, calcium, magnesium, zinc; at least 2-hour gap)
  • Biotin (vitamin B7)
  • Alcohol and thiamine-deficient states
  • Cytotoxic chemotherapy (oral use during curative-intent regimens)
  • Glucose-lowering supplements (chromium, cinnamon, berberine)
  • Other redox supplements (high-dose vitamin C, N-acetylcysteine, glutathione donors)
    •

Risk & Side Effects

  • High: Gastrointestinal Upset
    •
  • Medium: Topical Scalp and Skin Irritation
    •
  • Low: Insulin Autoimmune Syndrome; Seizures and Multi-Organ Failure After High-Dose Ingestion; Additive Blood-Sugar Lowering with Glucose-Lowering Drugs; Cutaneous Allergic Reactions After Oral Use; Autoimmune Membranous Kidney Disease
    •
  • Speculative: Mineral Depletion from Metal Chelation; Interference with Chemotherapy Efficacy
    •

Monitoring

Marker Target Why
Fasting plasma glucose 70–85 mg/dL Detect additive hypoglycemia
HbA1c 4.6–5.3% Tracks three-month glucose load
TSH 0.5–2.0 mIU/L Catch a thyroid-replacement interaction
Insulin antibodies Negative / laboratory-specific cutoff Confirm suspected autoimmune hypoglycemia
Scalp photo set Improvement versus own baseline; no universal millimetre target Only practical hair endpoint

Cadence: 4 weeks (tolerance, glucose, unexpected hunger or sweating); 12 weeks (first plausible hair-cycle window); every 3–6 months if continued. Home-glucose plan for the first 2 weeks when added to insulin or sulfonylureas.

Qualitative Assessment

  • Shed and coverage: daily change in shed hair from the drain versus the pre-course week
  • Gastrointestinal tolerance: nausea, reflux, metallic taste
  • Hypoglycemic symptoms: sweating, tremor, confusion, unexplained hunger
  • Local scalp comfort: itch or dermatitis on topical products
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.